Haochang Hu
Overview
Explore the profile of Haochang Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu D, Lu J, Yang Y, Hu W, Chen J, Xue J, et al.
Atherosclerosis
. 2025 Feb;
402:119110.
PMID: 39922081
Background And Aims: Calcific aortic valve disease (CAVD) is characterized by progressive leaflet thickening and calcification, with no available pharmacological treatments. Plasma proteins play a pivotal role in disease regulation....
2.
Lu J, Hu H, Xiu J, Yang Y, Zhu Q, Dai H, et al.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
. 2025 Jan;
49(8):1175-1186.
PMID: 39788507
Objectives: The high incidence of coronary artery heart disease (CHD) poses a significant burden and challenge to public health systems globally. Effective prevention and early diagnosis of CHD have become...
3.
Xie L, Chen J, Hu H, Zhu Y, Wang X, Zhou S, et al.
Bioact Mater
. 2024 Feb;
35:447-460.
PMID: 38390527
Atherosclerosis is featured as chronic low-grade inflammation in the arteries, which leads to the formation of plaques rich in lipids. M2 macrophage-derived extracellular vesicles (MEV) have significant potential for anti-atherosclerotic...
4.
Qian N, Wang Y, Hu W, Cao N, Qian Y, Chen J, et al.
Animal Model Exp Med
. 2024 Feb;
7(4):523-532.
PMID: 38372410
Background: Calcific aortic valve stenosis (CAVS) is one of the most challenging heart diseases in clinical with rapidly increasing prevalence. However, study of the mechanism and treatment of CAVS is...
5.
Chen J, Ren T, Xie L, Hu H, Li X, Maitusong M, et al.
Nat Commun
. 2024 Jan;
15(1):557.
PMID: 38228638
Calcific aortic valve disease is a prevalent cardiovascular disease with no available drugs capable of effectively preventing its progression. Hence, an efficient drug delivery system could serve as a valuable...
6.
Fang J, Qian Y, Chen J, Xu D, Cao N, Zhu G, et al.
Cardiovasc Res
. 2023 May;
119(11):2117-2129.
PMID: 37183487
Aims: The incidence of calcific aortic valve disease (CAVD) has risen over the last decade and is expected to continue rising; however, pharmacological approaches have proven ineffective. In this study,...
7.
Jiang X, Hu H, Qin Y, Hu Y, Ding R
Sci Rep
. 2022 Oct;
12(1):16802.
PMID: 36207371
An increasing number of researchers are using deep learning technology to classify and process garbage in rural areas, and have achieved certain results. However, the existing garbage detection models still...
8.
Hu H, Shu T, Ma J, Chen R, Wang J, Wang S, et al.
Front Genet
. 2021 Dec;
12:762587.
PMID: 34970301
As an autosomal dominant disorder, familial hypercholesterolemia (FH) is mainly caused by pathogenic mutations in lipid metabolism-related genes. The aim of this study is to investigate the genetic mutations in...
9.
Hu H, Chen R, Hu Y, Wang J, Lin S, Chen X
Lipids Health Dis
. 2021 Sep;
20(1):101.
PMID: 34511120
Background: As an autosomal dominant disorder, familial hypercholesterolemia (FH) is mainly attributed to disease-causing variants in the low-density lipoprotein receptor (LDLR) gene. The aim of this study was to explore...
10.
Lin S, Xu X, Hu H, Cheng J, Chen R, Hu Y, et al.
Pharmacol Res Perspect
. 2021 Mar;
9(2):e00751.
PMID: 33724726
Clopidogrel is widely used for antiplatelet therapy in patients with coronary artery disease (CAD), but clopidogrel resistance (CR) is relatively common in these patients. The goal of our study was...